Skip To Main Content
Related Cancers” on Muck Rack

Related Cancers”

As seen in: The Lancet, JHEP Reports
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Related

Contact Related, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Laparoscopic vs open surgery in posterosuperior liver resections: a negative trial with positive implications-the real value lies in perioperative management - The Lancet Regional Health - Europe

|
By Raffaele Brustia, Université Paris Est-Creteil, Related Cancers”, Hepato-pancreatic-biliary Surgery AP-HP
| The Lancet Verified
Hepatectomy by laparoscopy or open surgery? Which approach is better? For which indications? And based on what outcome criteria? These are the kinds of questions that could fuel a debate among hepatobiliary surgeons for hours—probably enough to leave them thirsty. The impact of laparoscopic approach has consistently divided surgical communities every time this technique was introduced into a new field.
Open in Who Shared Issue with article?

Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area

|
By Giuliana Amaddeo, Hôpital Henri-Mondor, Paris Est Créteil, Related Cancers”
| JHEP Reports Verified
Highlights • During the COVID-19 period, fewer patients with HCC presented to the multidisciplinary tumour board. • Globally, modification in the treatment strategy was observed in 13.1% of patients. • More than 21% of patients experienced a treatment delay >1 month in the COVID-19 period compared with 9.5% in 2019. • COVID-19 infection was the main reason for treatment delays in 2020. • In 2020, 7.1% of patients had a diagnosis of an active COVID-19 infection and 4/21 (19.1%) died.
Open in Who Shared Issue with article?
See all 2 articles